EDAP

EDAP TMS S.A. (NASDAQ:EDAP) is a French medical device company founded in 1979 and headquartered in Lyon, France. The company went public in 1997 and specializes in developing, manufacturing, and marketing minimally invasive medical devices for treating urological diseases. EDAP has evolved from a diversified medical device company into one increasingly focused on its High Intensity Focused Ultrasound (HIFU) technology platform, particularly for prostate cancer treatment. The company operates globally with direct sales operations in the United States, Europe, and Asia, serving hospitals, urology clinics, and research institutions worldwide.